Vishwadeepak Tripathi

Vishwadeepak Tripathi

Vishwadeepak Tripathi, PhD is a Global Market Manager at QIAGEN. He received his PhD in biochemistry at the Faculty of Medicine from Ruhr-University Bochum, Germany. Dr. Tripathi studied the role of chaperones and co-chaperones in protein folding and quality control and authored a number of scientific publications. He was also at RIKEN Institute in Japan where he studied the pathogenesis of Huntington's disease in cellular and mice models. He is currently interested in biomarker research, NGS and neurodegeneration.

S_2945_GG_Cardio_RP_700x233

Join our 2-part webinar series! Intro to qPCR and role of RNAs as biomarkers in cardiovascular research

Cardiovascular diseases (CVD) are a leading cause of morbidity and mortality worldwide. Preventative and therapeutic strategies focused on controlling traditional risk factors have not always been successful. Recently, the use of miRNAs as novel biomarkers in CVD has opened up new possibilities for discovering novel therapeutic targets and understanding CVD development. To date, the total… Read article →


Live qPCR webinar

Live webinar! The importance of controls and novel solutions for successful real-time qPCR

Reverse transcription quantitative PCR (RT-qPCR) is one of the most widely used methods for gene quantification today because it offers numerous advantages. High sensitivity, accuracy, speed and specificity are the key benefits that have made it a gold standard for gene expression analysis. However, a number of critical factors are involved during the various steps… Read article →


RNAlater post

Top 9 FAQs in RNA stabilization

Recently, we gave a series of webinars covering the different challenges and possible solutions for getting reliable gene expression profiles, with a focus on RNA extraction and stabilization from challenging samples. During these webinars, the audience had a variety of interesting questions. We would like to share with you our answers to the top 9… Read article →



ILLU_0890_SingleCell_HeterogeneityTumorPeople (1)

Understanding tumor heterogeneity with gene expression analysis

Strategies to counter tumor heterogeneity are high on the wish list of oncologists and cancer researchers. Within a single tumor, cells can differ in size, proliferation rate and ability to metastasize. Most significantly for physicians and patients, they can also differ in their sensitivity to chemotherapy. How can we best understand and investigate this aspect… Read article →